Immediately after giving effect to the PIPE Investment and the Business Combination, there were 153,648,830 shares of New Altus Class A common stock, 1,408,750 shares of New Altus Class B common stock and warrants to purchase 19,429,167 shares of New Altus Class A common stock outstanding.
Item 2.01 | Completion of Acquisition or Disposition of Assets. |
On December 6, 2021, CBAH held a special meeting at which the CBAH stockholders considered and adopted, among other matters, the Business Combination Agreement (the “Special Meeting”). On December 9, 2021, the parties to the Business Combination Agreement consummated the Business Combination. Pursuant to the Business Combination Agreement, the aggregate consideration paid to the Altus stockholders was 89,999,976 shares of New Altus Class A common stock at the reference price of $10.00 per share. The aggregate value of the consideration paid to Altus stockholders in the Business Combination was approximately $900 million.
Prior to the Closing of the Business Combination, holders of 19,101,146 shares of CBAH Class A common stock purchased in CBAH’s initial public offering exercised their right to redeem those shares for cash at a price of approximately $10.00 per share, or $191,022,688.79 in the aggregate.
Upon Closing, CBAH Class A common stock and warrants ceased trading and New Altus Class A common stock and warrants began trading on New York Stock Exchange LLC (“NYSE”). CBAH’s public units automatically separated into their component securities upon consummation of the Business Combination and, as a result, no longer trade as a separate security.
As of the Closing Date, the directors and executive officers and affiliated entities of New Altus beneficially owned approximately 71.5% of the outstanding shares of New Altus Class A common stock (including shares that may be issued upon exercise of our outstanding warrants), and the former securityholders of CBAH beneficially owned approximately 14.5% of the outstanding shares of New Altus Class A common stock (without giving effect to any shares purchased by such persons in the PIPE Investment and excluding shares that may be issued upon exercise of our outstanding warrants).
FORM 10 INFORMATION
Immediately prior to the Closing, CBAH was a shell company, other than a business combination related shell company, as those terms are defined in Rule 12b-2 under the Exchange Act. Pursuant to Item 2.01(f) of Form 8-K, New Altus, as successor registrant to CBAH, is providing the information below that would be included in a Form 10 if New Altus were to file a Form 10.
Cautionary Note Regarding Forward Looking Statements
This Current Report on Form 8-K and the information incorporated herein by reference include statements that express New Altus’s management’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results and therefore are, or may be deemed to be, “forward-looking statements.” These forward-looking statements can generally be identified by the use of forward-looking terminology, including the terms “anticipate,” “believe,” “could,” “continue,” “expect,” “estimate,” “may,” “plan,” “outlook,” “future” and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These statements, which involve risks and uncertainties, relate to analyses and other information that are based on forecasts of future results and estimates of amounts not yet determinable and may also relate to New Altus’s future prospects, developments and business strategies. These statements are based on New Altus’s management’s current expectations and beliefs, as well as a number of assumptions concerning future events.
Such forward-looking statements are subject to known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside CBAH’s or Altus’s control that could cause actual results to differ materially from the results discussed in the forward-looking statements. These risks, uncertainties, assumptions and other important factors include, but are not limited to:
| • | | the ability to maintain listing on the NYSE following the Business Combination; |
3